CIK 0001838716 · Non-accelerated filer<br>Emerging growth company
Genenta Science S.p.A.
Sign in to watch- Ticker
- GNTA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- Incorporated
- Italy
- Entity type
- other
- Phone
- 39-02-2643-6639
- Business address
- OLGETTINA, NO. 58, MILAN, Italy, 20132
- Former names
- Genenta Science S.r.l.
Securities
- GNTA Common stock Nasdaq
- SAEN American Depositary Shares Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-30 | Paracchi Pierluigi Chief Executive Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2026-03-30 | Galimi Francesco CMO& Head of Development | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2026-03-30 | PARACCHI GIACOMOANTONIO Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2026-03-30 | Sharei Armon Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2026-03-30 | Mutti Miguel Maria Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2026-03-30 | SLANSKY RICHARD B Chief Financial Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 |
Page 1 of 1 · 6 trades